News

Find News

Filter articles

Showing 2431 to 2440 of 2541 results

Judge denies AstraZeneca’s bid to squash pay-for-delay challenge

US27-09-2013Legal developments

A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium.

MyMedicalRecords sues over online health checks

US26-09-2013

A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company.

South Africa could overhaul patent policy

26-09-2013

The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system.

Japan and India to launch new research centres

Japan, US25-09-2013

A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students.

Teva holds on to Azilect exclusivity

US25-09-2013

The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect.

Ranbaxy receives notice for acne drug generic

US24-09-2013

Drug company Watson Laboratories (Actavis) has notified rival Ranbaxy Laboratories that it has applied to sell a generic version of anti-acne product Absorica in the US.

Boston Scientific and OrbusNeich settle patent cases

Germany, Netherlands, Republic of Ireland, UK, US18-09-2013Legal developments

Medical device makers Boston Scientific and OrbusNeich announced on September 17 that they have settled all stent-related patent litigations.

Eli Lilly sues Canadian government for “unfair” patent rulings

Canada17-09-2013Legal developments

Eli Lilly has filed a NOA against the Canadian government, alleging recent decisions that invalidated patents covering its Zyprexa and Strattera drugs were in breach of NAFTA.

Foreign drug makers claim monopoly on Indian patents

16-09-2013

The Indian government has awarded more than two thirds of its recent pharmaceutical patents to foreign drug makers, according to data released by the Indian Patent Office.

India recommends compulsory licence for anti-cancer drug

India12-09-2013

The Health Ministry in India has recommended that a compulsory licence is issued for the manufacture of Bristol-Myers Squibb’s anti-cancer drug Sprycel (dasatinib), potentially opening the door to the sale of cheaper imitations.

Showing 2431 to 2440 of 2541 results

LSIPR